Category: News

A little over a month ago, two ministries of a country at war sat down and wrote a public letter asking the oldest film festival in the world to take a film out of competition. The festival said no. Three weeks later, the jury handed that same film’s director one of the biggest prizes on the Lido, and the director, standing there with it, said the thing almost nobody expected him to say. He said he wished the government that had tried to get him removed every success in saving its country and winning its war.

That is the whole shape of it, and almost nothing about it is simple.

The film is called DAU, and it arrived at the 83rd Venice International Film Festival carrying about seventeen years of argument on its back. Its director is Ilya Khrzhanovsky, born in Moscow in the mid 1970s, resident outside Russia since 2007, and, since Russia’s justice ministry designated him a foreign agent, no longer a Russian citizen at all. He renounced it. He now holds British, German and Israeli citizenship and lives in Berlin. His passport, or rather the absence of the one everybody assumed he had, sits underneath every part of this story.

Before the festival even opened, Ukraine’s foreign and culture ministries issued a joint statement objecting to DAU’s place in the main competition. Their case was not that the film was bad, and it was not, on its face, that the director was Russian. It was about money, networks and what a stage like Venice confers. At a time when Russia was continuing a war of aggression against Ukraine and systematically destroying its cities, its cultural heritage and its national identity, the ministries argued, handing one of the most prestigious cultural platforms in the world to a project linked to the Russian state and its networks of influence sent an extremely troubling signal. They said Russia treats culture as an instrument of state policy and hybrid warfare, and that accepting Kremlin adjacent projects lets Moscow test how far international institutions are willing to tolerate its crimes.

They were specific about why they thought DAU qualified. The project’s early financing came from Sergei Adoniev, a Russian businessman later placed under sanctions. Khrzhanovsky had gone on to run a major cultural institution funded by oligarch money. And the film’s lead performer, the conductor Teodor Currentzis, had been granted Russian citizenship by presidential decree and has declined, repeatedly, to criticise Vladimir Putin. Currentzis’s orchestras have received Russian institutional funding. Ukraine’s embassy in Italy raised the same objection through diplomatic channels. Put together, the ministries’ argument was that you cannot separate a work from the pipes the money ran through, and that a festival which pretends you can is doing the propaganda work for free.

That is a serious argument, made by a state whose cultural institutions have been bombed, and it deserves to be stated at full strength rather than waved at.

The festival’s answer was unusually blunt. Alberto Barbera, Venice’s artistic director, refused to pull the film and said the campaign against it was a manipulation of reality. He said DAU is not pro Putin propaganda. He said it is not a Russian film at all, and that what it actually does is denounce totalitarian regimes. He called the effort to have it removed a petty and unacceptable act. Festival directors under pressure from a government usually reach for something diplomatic about artistic freedom and leave it there. Barbera did not.

His position, stated at its strongest, is this. If the content of a film condemns authoritarian power, and if its director has renounced the citizenship of the state accused of backing him, then removing it because of where money came from nearly two decades ago is not resistance to propaganda. It is a test the festival would be failing in the other direction, by letting any government decide which artists are acceptable. And if the standard is association rather than content, it is a standard almost no international co production could survive.

Both of those cases are coherent. Neither of them is silly. And the reason this row travelled so far beyond film people is that most of the arguments in the world right now have exactly this shape, where the question is not whether a thing is good but whether the people behind it have earned a hearing.

To understand why DAU in particular is such a strange object to be arguing about, you have to know what it is, and almost nobody outside a fairly small circle does.

Around 2008, Khrzhanovsky set out to make a biographical film about the Soviet physicist Lev Landau, known to colleagues as Dau. What he built instead, in Kharkiv, in Ukraine, was a twelve thousand square metre reconstruction of a Soviet research institute, and then he moved people into it. Roughly four hundred participants, most of them not professional actors, lived inside that reconstruction under period rules, in period clothing, with no modern objects permitted, for stretches at a time. The unscripted shoot ran from late 2009 to late 2011. It generated around seven hundred hours of 35mm film, which was eventually cut into fourteen features and three series plus installation work. The film that competed at Venice runs three hours and fifteen minutes and follows Currentzis as a physicist moving through Soviet life across four decades.

It is not, by any measure, a normal movie, and it has never been treated as one.

The project has been controversial on its own terms since long before any of this, and it would be dishonest to write about the Venice row without saying so. When an earlier DAU film screened at a major festival years ago, a group of Russian journalists published an open letter attacking its selection. There have been sustained allegations about the conditions inside the institute and about how far the line between performance and real experience was allowed to blur, including a claim that an intimate scene was filmed without the performers’ knowledge, which the lead actress herself denied. Khrzhanovsky has addressed the accusations publicly rather than ignoring them, and has argued that the emotional register of the work is meant to be hard to sit through. Nobody has ever been able to settle the argument to everyone’s satisfaction, partly because the project’s whole method was to make the boundary between the thing and the depiction of the thing impossible to locate. Anyone who tells you the ethics of DAU are a solved question is selling something.

There is one more layer, and it is the one that makes Ukraine’s objection more complicated rather than less.

For several years, Khrzhanovsky was artistic director of the Babyn Yar Holocaust Memorial Center in Kyiv. Babyn Yar is the ravine where tens of thousands of Jewish civilians were murdered during the German occupation, and the plan to build a major memorial there became, under his tenure, one of the loudest cultural fights in the country. Critics, including Ukrainian historians and cultural figures, objected fiercely to his proposed immersive approach to memory, and objected too to the memorial’s funding sources. Others argued that the institution was doing serious historical work that had been neglected for decades. He left the role a few years ago, saying that the war had changed a great deal about how a culture of memory can be built in Ukraine.

So the man Ukraine’s ministries wanted removed from Venice is also a man who spent years working in Ukraine, whose defining project was built in a Ukrainian city that has since been shelled repeatedly, and who has publicly opposed the invasion since it began, including signing letters against it and helping arrange access for independent journalists to interview Ukraine’s president. His critics would say none of that cancels the money trail or the casting of Currentzis. His defenders would say it is precisely the record that the ministries’ statement leaves out. Both of those are positions people hold sincerely, and this piece is not going to pretend one of them has quietly won.

When reporters put Ukraine’s accusations to him in Venice, Khrzhanovsky did not do what most people do under that kind of attack, which is to counterattack. On the financing, he said plainly that Adoniev was the first financier of the project, from 2008 to 2019, before sanctions existed, and that in the seven years since then the project has had a completely different life and different money. On Currentzis refusing to condemn Putin, he declined to denounce him. He said some people make choices he does not like, and that everyone is responsible for their own choices, which is either an evasion or an unusually restrained refusal to throw a colleague under a bus, depending on where you are standing.

And then he said the line that made the story travel. Asked what he wanted, he said the only thing he could wish for was peace, and success for the Ukrainian government, that it succeed in the best possible way, that it save the country, and that it win this war.

That is a director, under public attack from two ministries of a state, wishing that state victory.

You can read it a few ways, and people did. The generous reading is that he refused to let a cultural row be converted into a reason to be lukewarm about a war he has been clear about for years, and that he separated a government’s decision about him from a country’s survival. The sceptical reading is that it was the single most disarming sentence available to him and he knew it. The honest position is that nobody outside his own head can settle which, and the sentence is on the record either way.

The festival ran its eleven days. At the closing ceremony, a jury chaired by Maggie Gyllenhaal, a jury widely read going in as one likely to be attentive to ethical questions about how films get made, gave Khrzhanovsky the Silver Lion, reported as the award for best director. Of all the outcomes available, it was the one guaranteed to keep the argument alive. A quiet exit from competition would have ended the story. A prize did the opposite.

One detail that has circulated since deserves flagging rather than repeating. Some coverage has reported that Khrzhanovsky dedicated the award to Ukraine from the stage. That claim traces back to secondary outlets and could not be confirmed against the ceremony record, so it is left where it belongs, unverified. What is solidly documented is the earlier answer, given to reporters at the festival, about wishing the Ukrainian government success in saving the country and winning the war. The reason the two keep getting fused in retellings is obvious, because the second makes a neater story, and neat is usually the first sign that something has been smoothed.

There is a detail in all this that keeps getting lost, and it is the one that would matter most to anyone who ever walked through the set. The institute was built in Kharkiv. Kharkiv is a city that has been under bombardment on and off since the invasion began, close enough to the border that air raid warnings there have at times been measured in seconds rather than minutes. Whatever anyone thinks of the project’s methods, the place where four hundred people spent two years living inside a reconstructed Soviet institute is now a front line city, and the country that hosted the strangest film production in modern European history is the same country whose ministries asked for its result to be pulled from competition. That is not an argument for either side. It is just the fact that sits underneath both of them.

The other thing that keeps this from being a one off is the precedent question, and everybody involved knows it. Since the invasion, every major festival, orchestra, opera house and museum in Europe has had to decide, case by case and usually without a written rule, what to do with Russian born artists, with work funded years ago by people who are now sanctioned, and with performers who will not say publicly what they think of the government at home. Some institutions drew the line at the state, some at the individual, some at the money, and a few drew no line at all and took the criticism. Venice’s decision on DAU is now one of the loudest data points in that record, and whichever way you think it should have gone, the next institution facing the same call will be looking at it.

So where does it actually settle.

Ukraine’s ministries did not get the film removed and have not withdrawn their objection. Their argument about cultural platforms as instruments of legitimacy is one that other institutions are going to face again, because the underlying question of whether a work can be assessed separately from its financing has no agreed answer anywhere in the arts. Barbera did not apologise and the festival’s position has not moved. The film went out into the world with a major prize attached and an asterisk that will follow it into every review. Khrzhanovsky went back to Berlin with a Lion, no Russian passport, a body of work that is still genuinely contested on its ethics, and a sentence about somebody else’s war that will probably outlast the prize.

What is worth holding onto is how rare it is to see any of these parties behave the way they did. A state at war spent diplomatic effort on a film rather than ignoring it, because it believes culture is a front. A festival refused a sympathetic government’s request in public and gave its reasons. And a director who had every incentive to be aggrieved used his moment to wish the people who came after him well. None of that resolves anything. All of it is on the record, which, in an argument this loud, is the most anyone is likely to get.

Within about ten days, Ed Sheeran’s stadium tour went from having a full bill of opening acts to having none at all.

Four of them walked. A rapper who had already been playing the run was removed by the promoter. And the last of the four to go had been standing on that stage every single night for months, not as a support act but as part of Sheeran’s own set. By the time it was over, one of the biggest touring operations in the world was heading into its remaining stadium dates with nobody scheduled to go on before the headliner.

The money involved is not small, and that is the part that tends to get lost. A stadium support slot is one of the few things in music that can genuinely change a career. You play to fifty or sixty thousand people who did not come for you, you get paid, and if it goes well a meaningful slice of that crowd goes home and looks you up. Artists spend years angling for exactly this. Four of them handed it back inside a week.

It helps to understand what the job actually is, because most people picture it wrong. An opening act on a stadium run is not a guest. They are contracted, usually months in advance, with a fee per show and a production budget they often have to part-fund themselves. They travel with a crew. They rehearse a set built specifically for a stage that size, which is not the set they play in clubs, because a room of sixty thousand people needs bigger, simpler songs and a different kind of pacing. Pulling out of a run mid-way does not just cost the remaining fees. It strands the crew, wastes the production spend, and leaves a hole in a touring schedule that was blocked out a year ago and cannot be refilled at a week’s notice.

It also burns a relationship. The touring business is small at the top. The same handful of promoters, agents and venue operators control most of the stadium calendar in any given country, and they have long memories. An artist who walks off a bill is not just declining one payday. They are making a note in a file that other people will read the next time a slot comes up.

Here is what happened, and it is worth laying out carefully, because almost every account of it starts from a conclusion.

Sheeran has been on the road since the start of the year with the Loop Tour, supporting his album Play. It is his sixth tour and it is enormous: fifty-nine shows across Oceania, Latin America and North America, running most of the year. Through the seventeen shows counted in one mid-tour tally it had drawn more than 750,000 people and taken in something close to 99 million dollars. Sydney alone reportedly grossed around 26 million dollars. Opening night in Auckland drew close to 56,000 people. These are the numbers that make a support slot valuable, and they are also the numbers that make everyone involved extremely cautious.

The tour used rotating openers depending on the region. Among them at various points were Vance Joy, Mia Wray, Myles Smith, Sigrid, the Danish band Lukas Graham and the American rapper Macklemore. Separately, the Irish folk group Beoga had been appearing inside Sheeran’s own set since the start of the tour, playing alongside him rather than before him. Beoga are long-standing collaborators of his; their sound is threaded through some of his best-known songs.

In early September, at a stadium show in New Jersey, Macklemore introduced Hind’s Hall, a protest song he released in 2024 about the war in Gaza, and called out Free Palestine from the stage.

Days later he was off the tour.

Macklemore’s own account is that the removal was not a decision made inside Sheeran’s camp. He said publicly that Robert Kraft, the billionaire owner of the New England Patriots and of Gillette Stadium, had rallied fellow stadium owners to keep him off the bill. That is his characterisation, and it is worth flagging as such.

Kraft responded, and his position is specific. He said the decision was not about Palestinian suffering, which he acknowledged, but about what he described as Macklemore’s broader history of antisemitic rhetoric and imagery, which he said was deeply offensive and hurtful to the Jewish community. He also said he would welcome the chance to sit down with Macklemore and talk it through, on the grounds that both of them ultimately want peace. Macklemore has previously faced accusations of antisemitism in connection with his work and public statements, and has previously rejected them.

The promoter, Messina Touring Group, put the practical problem in the plainest possible terms. Venues had told them they would not allow a concert to go ahead with Macklemore on the bill. If the venues held that line, the shows would not happen at all, and hundreds of thousands of people holding tickets would find their concerts cancelled.

That is the squeeze. Not an argument about a song, but a set of buildings saying no, a promoter contracted to deliver shows in those buildings, and an artist whose name is on the tickets.

Sheeran did not say anything publicly until after Macklemore was already gone, which several people have pointed to as the hinge of the whole thing. When he did speak, he was direct about where the decision came from. He said Macklemore coming off the tour was the promoter’s decision and not his. He said venues had threatened to pull the shows if Macklemore stayed. He said he had tried to mediate, working with promoters and with activists on both sides. He said he was appalled by the conflict between Israel and Palestine. And he said there was a reason he does not use his professional platform for politics, which is that his audience includes a lot of young people and children from every kind of background, and he wants his shows to be a place of safety and sanctuary. He also said, plainly, that he was not complicit.

You can read that as a reasonable account of a man with limited control over which buildings will host him, or as a headliner declining to spend the leverage that only headliners have. Both readings have been argued in public by people with a genuine stake in the outcome. What is not in dispute is the sequence: the removal happened first, the statement came after.

Then the bill emptied out.

Finneas went first, or first among the announcements. He is a producer and songwriter who has won a shelf of Grammys, most of them for work with his sister Billie Eilish, and he had four South American dates with the tour ahead of him. He said artists must not be silenced when they speak up for the oppressed, that he had decided to withdraw from his upcoming dates with Sheeran, and that he stands with Palestine and its people.

Finneas is not a struggling opener. He has an established career of his own, and a body of production and songwriting work with his sister that has collected Grammys and Academy Award recognition. He can afford to lose four shows, which some people used to discount the decision and others used to argue the opposite: that he was the one act on the bill who could take the hit, and took it.

Aaron Rowe, a young Irish singer-songwriter, withdrew from the remaining North American dates. In explaining the decision he pointed to Irish historical experience of famine, occupation and dispossession as the reason the situation was not something he could sit out, and ended with Free Palestine. Similar reasoning was attributed in other reports to Beoga, which is not surprising given both acts are Irish and the argument is a common one in Irish public life; the exact wording has been reported inconsistently across outlets, so take the sentiment as attributed rather than the phrasing as exact.

Lukas Graham are not newcomers either. The Danish band had a global hit with 7 Years that put them in front of an audience most acts never reach, and they had been among the tour’s rotating openers rather than a one-off booking.

Lukas Graham left too, and his statement was the most personally uncomfortable of the four. He said he loves Ed and is grateful for everything they have shared, and that this had not changed, but that he could not put those words out into the world and then carry on with the tour as things stood. He also said money does not give you the right to own the conversation.

Beoga were the last and, in some ways, the biggest loss to the actual show, because they were not an opener who plays for half an hour and leaves. They were built into Sheeran’s set. Their stated reason was that they would not play in venues that, as they saw it, silence anyone advocating for a free Palestine.

There is a detail in Beoga’s situation that makes it sting more. Their collaboration with Sheeran predates this tour by years and runs through some of his most widely played songs, where their fiddle and accordion are a large part of why those tracks sound the way they do. Leaving the tour did not end that history, but it ended the arrangement where they got to stand on stage and be visible for it.

Add it up and the cost is real and specific. Four acts gave up guaranteed stadium fees, the travel and production costs already sunk into preparing those shows, and the exposure that is the entire economic argument for taking a support slot in the first place. For Finneas, who has an independent career and a famous surname, the financial hit is survivable. For Aaron Rowe, who is at the stage where a stadium run is the difference between a career and a hobby, it is not a small thing at all. For Beoga, it meant walking away from a working relationship with one of the biggest artists on earth that had produced some of their best-known work.

None of the four appears to have been forced out. They chose, and they chose knowing what the slot was worth, which is the part that makes this more than a news cycle.

It is also worth being honest about what is unresolved. Nobody in this story got what they wanted. Macklemore is off a tour he was booked on. Kraft’s stated objection, that a pattern of imagery and language crossed into antisemitism, has not been retracted and has not been accepted by the other side. Sheeran is playing stadiums with no support act and no obvious way to satisfy anyone by saying more. The four acts who left have made a stand that costs them and changes nothing about the underlying disagreement. The promoter avoided cancelling shows and absorbed a public relations disaster instead.

There is a version of this story that treats it as a scoreboard, with a winning side and a losing one. That is not what the record shows. What the record shows is a commercial structure that almost nobody in the audience ever thinks about. Artists do not book stadiums. Promoters book stadiums. Stadiums are owned by people with their own interests, their own politics and their own contracts, and those owners can decline to open the doors. That structure is invisible for years at a time and then, when something political touches it, it becomes the only thing that matters.

The tour carried on. The remaining North American stadium dates went ahead on schedule, including two nights at Gillette Stadium, the venue owned by the man at the centre of it, with a shortened bill. Sheeran did not issue a further statement after the four withdrawals. The rest of the year’s dates, running through to December, remain on the books.

What happens to the people who walked is the part still being written. In the short run they lost money and stage time. In the longer run, they did the thing that is hardest to do in an industry built on access, which is to make themselves less available to someone more powerful than they are. Some of them will find that door heavier to open next time. Some of them will find that an audience remembers who left and why.

Either way, all four knew the number on the contract before they said no. That is what makes it a decision instead of a gesture.

The women who have finally been paid are in their sixties, seventies and eighties now. Some of them have spent most of their adult lives not knowing why they could not have children, or why something inside their bodies hurt, or why a doctor at some point looked at a scan and asked them a question they had no answer to. The payments landed in their accounts recently, about 300,000 Danish kroner each, roughly $47,000. It is the first money any of them have received for something that was done to them as schoolgirls, in some cases sixty years ago.

The Danish state has a formal name for what happened, and the Danish and Greenlandic press have a short one. In Danish it is the coil case, or the spiral case, after the contraceptive device at the centre of it. Between the early 1960s and the start of the 1990s, thousands of Greenlandic girls and women were fitted with intrauterine devices by a health service run from Copenhagen, and a great many of them were not told what was being done, were not asked, and did not agree to it.

An official investigation ordered by Denmark and Greenland and published last year found that by the end of 1970 alone, around 4,070 Greenlandic women and girls had been fitted with coils. To understand what that number means you have to put it next to the size of the population it came from. Greenland at the time had somewhere in the region of nine thousand women of childbearing age. The investigators put it plainly: this amounted to something like every second Greenlandic-born woman.

The investigation examined the accounts of 354 women. Among those cases, it could find documentation that the woman had actually given informed consent in 47 of them.

Some of the girls were twelve years old.

The reason any of this became known is that a woman named Naja Lyberth decided, years ago, to say out loud what had happened to her. She is a psychologist, and she lives in Nuuk now. She was thirteen, living in Maniitsoq on Greenland’s west coast, when she was sent to the hospital for a procedure she had not asked for and did not understand. She has described what it did to her, physically and otherwise, in her own words and on her own terms, over and over, in interviews and in writing, for the better part of a decade. She has said she believes it affected her ability to have children. She has been blunt about what a girl that age loses when an adult in a white coat does something like that to her and calls it healthcare.

What she did next mattered more than any single account. She started a group online where other Greenlandic women could find each other, and they did, in numbers. Women who had thought they were alone with a private medical mystery discovered that their friends, their cousins, their classmates, women from the same small towns and the same school years, had the same story. Some of them had gone through miscarriages and complications and years of pain. Some had only learned what was inside them decades later, by accident, during an unrelated examination. Several have said the worst part was not the discovery but the arithmetic that followed it, working backwards through their own lives and realising what had been decided for them before they were old enough to have an opinion.

Lyberth has been named internationally for this work, including on the BBC’s list of a hundred women a few years back, and a photographer’s documentary series about the survivors won a major international award. None of that was the point. The point was that once dozens of women were telling the same story, it stopped being anecdote and became a matter that a government had to answer.

What turned a group of women talking among themselves into a national reckoning was a piece of journalism. Danish public radio built a documentary series around the case a few years ago, and its reporters went into the archives and came back with the campaign’s own paperwork, the records of a programme that had been documented at the time and then simply left to sit. Within weeks Greenland’s parliament had voted to demand an investigation, and the Danish and Greenlandic governments agreed to run one together.

That sequence says something about how this stayed hidden for so long. It was not lost. The files existed. What was missing was anyone with the standing to insist that somebody read them, and for decades the women who could have insisted had been raised not to.

Lyberth has made that point herself, and it is one of the more devastating things she has said. She has described how everything about the way she was brought up made it close to impossible to argue with a doctor or to walk out of the room. A thirteen year old in a small town, sent by adults to an adult, in a system run in a language and a manner imported from somewhere else, does not refuse. The campaign relied on that, whether or not anyone designing it ever wrote the reliance down.

The women who have spoken publicly have described decades of pain, of complications, of surgeries, and of a shame they had no reason to carry and carried anyway. Several have described the years afterwards as time spent frozen inside their own bodies. They have been careful, in nearly every public account, to put the emphasis on the same place: that the ability to decide whether to have children is not a medical preference but something that belonged to them and was taken. In 2023 the campaigners were given Denmark’s own human rights award, which a number of them noted was a strange and welcome thing to receive from the country they were suing.

The history underneath it is the awkward part, and it is not ancient. Greenland was a Danish colony until 1953 and then a Danish county, and Denmark ran its health service until 1992. In the post-war decades there was open official concern in Copenhagen about Greenland’s birth rate and about the cost of the population growing faster than the housing and the schools could absorb. The coil campaign was run against that background. Whether it is best described as a deliberate policy of population control or as a public health programme that trampled consent is the exact question that Danish and international experts have not fully agreed on, and the disagreement is not cosmetic. The independent investigation’s Danish framing leaned towards treating the failures as serious but not systematically directed, while human rights scholars looking at the same record have argued the pattern is too consistent and too one-sided to read as a series of individual lapses. Greenlandic women who lived it have largely made clear which reading they recognise.

What is not in dispute is that it continued. The commonly used window for the case runs from 1960 or 1965 to 1991, and the practice did not stop neatly at the moment Greenland took over its own health system. That is why there are now two compensation tracks rather than one. Denmark is paying for what happened while it ran the service. Greenland’s own authorities have set up a separate scheme for cases after the handover, which is an uncomfortable inheritance for a government that had no part in designing the original campaign.

The Danish prime minister, Mette Frederiksen, apologised last year, alongside Greenland’s leader Jens-Frederik Nielsen. She said the women had been wronged, and specifically pushed back on the idea that you can excuse what happened by saying it was simply how things were done at the time. That framing matters, because the most common defence of historical state conduct is exactly that one, and it was rejected by the person holding the office that would have benefited from it.

An apology is not money, and the women had been asking for money for years before this. In 2023 Lyberth and dozens of others filed claims. By early 2024, 143 Greenlandic women were pursuing Denmark for compensation of 300,000 kroner each, and the state’s initial legal posture involved the ordinary machinery of limitation periods, which is to say the argument that too much time had passed. That argument was legally available and morally impossible, given that the whole reason time had passed was that the women were never told what had been done to them. Any clock that starts when the wrong occurs is useless when the wrong was concealed from the person it happened to.

Eventually the political answer arrived. A compensation law was passed with support across the Danish parliament, having been delayed by a general election and the business of forming a government. Applications opened in the middle of this year, the legislation took effect at the start of September, and the first approvals followed almost immediately. The scheme sets a flat figure of 300,000 kroner per woman, about $47,000. The government has estimated that as many as 4,500 women could be eligible, although the true number is genuinely unknown and sources differ, which is why nobody involved is quoting it with confidence.

The scheme covers more than coils. It extends to women given contraceptive implants or injections without informed consent in the same period, which widens it beyond the device the case is named after. It also, in certain circumstances, covers women of Greenlandic background living in Denmark who went through comparable treatment and retain a strong connection to Greenland.

The claims are handled by Patienterstatningen, the Danish patient compensation body, which is the same organisation that processes ordinary medical injury claims. That is an efficient choice and a strange one. It means that women in their seventies and eighties are now completing claim forms about hospital appointments from their childhood, appointments whose purpose was deliberately not explained to them, and being asked to describe on paper what happened in a room they were taken to before they were old enough to refuse.

In the first month the scheme was open, 171 women filed. The head of the compensation body’s secretariat has said he expects many more before the deadline, and has been frank about the reason for the slow start, which is that writing it down means living through it again. Women who have spent fifty years not talking about something do not fill in a form about it in the first week.

The deadline itself is the sharpest of the outstanding criticisms. Claims must be in by 2028, and Greenland’s human rights council has objected on a simple, factual ground: doctors are still finding coils in women who did not know they were there. If a woman has not yet discovered what was done to her, a cut-off date is not a neutral administrative detail. It is a way of closing the file before everyone it concerns has found out they are in it.

There are other limits that the women’s advocates have raised and that are not fully resolved. The scheme is a state payment scheme, not a court judgment, and it does not produce the findings of fact that a trial would. A flat sum treats very different lives identically, which is either fair or crude depending on where you are standing. Greenlandic critics have also argued that the investigation into what happened was conducted largely on Danish terms, without enough Greenlandic authorship over how the history gets written, and several have called for a truth commission rather than a report and a payout. That argument is about something a bank transfer cannot address, which is who gets to say what this was.

And there is the plain fact that many of the women this was done to are already dead. They spent entire lives not knowing, or knowing and never being believed, and no scheme opening in 2026 reaches them.

What is left is the thing the women themselves have generally named as the point, which is not the size of the payment. Almost all of them have said some version of the same thing over the years: they wanted it acknowledged, in writing, by the state, that it happened and that it was wrong. For decades the answer they got was silence, or the suggestion that they were misremembering, or the observation that medical practice was different back then. The money is worth roughly $47,000 and functions mainly as proof. It is a document you can hold that says the state agrees with your account of your own life.

Lyberth has said that what she has always wanted is for the women to be believed while they are still here to be believed. That is now partly done. The first of them have been paid. The rest are working through the forms, slowly, at whatever speed a person can manage when the paperwork is about the worst thing that ever happened to them.

It took sixty years, an apology, a change in the law and a woman who refused to keep it to herself. The envelopes are late beyond any possible defence. They did arrive.

For roughly two years, a seafood wholesaler in Dallas bought farmed salmon that had been raised in Chile, put it in boxes marked as salmon from Scotland, Norway and Canada, and sold it on. Restaurants bought it. Retailers bought it. Somewhere at the end of that chain, an unknown number of people ordered the more expensive fish, ate it, and had no way on earth of knowing.

The company has since pleaded guilty. Seafood Supply Company, a wholesaler operating out of Dallas, admitted two felony counts of false labelling under the Lacey Act, was fined 250,000 dollars, placed on three years of probation and ordered to put an environmental compliance plan in place. According to the court documents, a conservative estimate of what the scheme earned the company is around 200,000 dollars. Prosecutors put the conduct between the start of 2020 and early 2022.

No individual employees were charged. The company itself was the defendant, it entered its plea earlier this year, and it was sentenced a few months later. It now operates under different leadership, with a new president appointed around the time the plea was entered.

That is the whole case, and on paper it is small. A quarter of a million dollars is not a headline number in federal court. What makes it worth sitting with is not the size. It is the fact that it was possible at all, and that the only reason anyone ever found out is that the origin of a fish has quietly become something you can prove.

Start with why a wholesaler would bother. Chile and Norway are the giants of farmed Atlantic salmon, between them producing most of what the world eats. Scotland produces far less, and sells much of it on the strength of exactly one thing: where it comes from. The same is true, in different ways, of Norwegian and Canadian product. Origin is not a neutral descriptor on a salmon box. It is the premium. Two fillets can be the same species, farmed in the same kind of net pen, fed similar feed, processed on similar lines, and command noticeably different prices because of the word printed above the weight.

Which means the gap between what Chilean salmon costs and what Scottish salmon costs is pure margin to anybody willing to change the word. The court documents in this case put it about as plainly as a legal filing ever does: Chilean salmon was cheaper than product from Scotland. That is the entire business logic.

And here is the uncomfortable part for anyone who has ever paid up for the better fish. Once a salmon has been filleted, chilled and boxed, a farmed Atlantic salmon from Chile and a farmed Atlantic salmon from Scotland are the same species, the same colour and the same texture. There is no tell. A chef cannot spot it. A fishmonger cannot spot it. A supermarket buyer receiving pallets cannot spot it. The label is not a description of the product you can check against the product. For everyone downstream, the label simply is the product.

That is what makes origin fraud different from the more familiar kind of seafood fraud, where a cheap fish is sold as an expensive one. Species swaps can at least be caught by anyone who knows what a fish looks like, and they have been caught repeatedly. The conservation group Oceana has run DNA testing programmes on retail seafood for years, and its salmon work is worth knowing about: in one study of 82 salmon samples bought from restaurants and grocery stores during the winter off-season, 43 percent turned out to be mislabelled, the large majority of those being farmed Atlantic salmon sold as wild-caught. That study is over a decade old now and the sample was small, but the pattern it exposed has held up across a lot of subsequent testing. When wild salmon is in season and plentiful, mislabelling drops sharply. When it is scarce and expensive, it climbs.

Origin fraud is harder than that, because the DNA is identical. The fish is telling the truth about what it is. It is the box that is lying about where it lived.

So how do you catch it? Partly by paperwork, which is the unglamorous answer, and partly by science that has come a long way in a short time. Government forensic laboratories now maintain genetic reference libraries covering hundreds of commercially traded seafood species, and the US food regulator has worked with the Smithsonian Institution to build a public sequence database that both government and private labs can test against. DNA barcoding works on raw fish, cooked fish, frozen fish, canned fish and dried fish, which closes most of the routes a species swap used to travel.

For origin specifically, the emerging tools lean on chemistry rather than genetics. Water, feed and local geology leave traces in a fish’s flesh, and the ratios of certain stable isotopes and trace elements differ between farming regions. The techniques are not yet a routine checkpoint at every port, and researchers working on them are careful about overstating how precise they are. But the direction of travel is clear. Origin is becoming a testable fact rather than a claim you simply have to take on trust, which is an enormous change in a trade that ran on trust for its entire history.

The investigation that caught this particular wholesaler was run by the enforcement arm of the US ocean agency, as part of a wider operation targeting fraud in the seafood supply chain, and prosecuted by the environmental crimes lawyers at the Department of Justice. The statute they used is the interesting piece.

The Lacey Act was signed into law in 1900. It was written by a congressman from Iowa named John Lacey, and its original target had nothing to do with fish. It was aimed at the trade in wild birds, which were being shot in enormous numbers so their feathers could go on hats, and at hunters who poached game in one state and sold it in another where the local laws could not reach them. The core idea was elegant and has outlasted everything around it: make it a federal offence to transport or sell something across a border if it was taken, possessed or sold in violation of any other law.

Over more than a century, that frame was extended to fish, reptiles, amphibians, molluscs and crustaceans, then in 2008 to plants and timber, which is how it ended up being used against illegally logged wood. A set of amendments in the early 1980s added the false labelling provision, which is the one that applied here. It is the same statute that has been turned on ivory traffickers and illegal loggers, and it is why a mislabelled box of salmon is a federal felony rather than a consumer protection ticket.

This is where the case stops being a curiosity and starts being a window, because the enforcement picture behind it is thinner than most people assume.

The US imports the large majority of the seafood it eats. The main screening system for that flow is a monitoring programme that requires importers to submit chain of custody information, covering where a fish was caught, by which vessel, under which flag, with what gear, when it was landed and who handled it afterwards. That programme covers thirteen species groups, chosen because they are considered most vulnerable to illegal fishing: abalone, Atlantic blue crab, Atlantic cod, dolphinfish, groupers, Pacific cod, red king crab, red snapper, sea cucumbers, sharks, shrimp, swordfish and tunas.

Read that list again and notice what is not on it. Salmon. Farmed Atlantic salmon, the fish at the centre of this case and one of the most heavily traded seafood products in the world, is not covered by the programme at all.

Even for the species that are covered, the coverage is partial. The programme takes in roughly a third of US seafood imports by volume. Of the imports that do fall under it, the share actually audited over a recent multi-year stretch was about half of one percent, and a congressional research review found that most of the violations picked up were reporting errors rather than detected fraud. Importer compliance with the programme’s own requirements fell from 57 percent to 42 percent across four years.

There is a second number that is even more striking. The ocean agency also runs a voluntary, fee-based inspection service that examines around a fifth of the seafood consumed in the country. Among products voluntarily submitted to that service, inspectors have found problems in up to 40 percent. Those are the products a business chose to send for inspection. It is not a random sample of the market, and businesses submit for all sorts of reasons, so the figure should not be read as a fraud rate for seafood generally. But it does not suggest a sector where the labels can be assumed to be right.

Put those pieces together and the Dallas case starts to look less like an outlier and more like a sighting. A scheme running for two years, through a functioning wholesale business, generating a couple of hundred thousand dollars of extra margin, in a species that the flagship import monitoring programme does not cover. It was caught, and that matters, but nothing about the structure around it suggests it was the only one of its kind.

It also is not the only one on record. The same enforcement arm has brought a run of similar cases in recent years, and the shape repeats. One company and its owner were penalised after relabelling foreign spiny lobster as a product of the United States and exporting it to China, roughly 5,900 pounds of it, with a retail value reported at more than 206,000 dollars; the owner received five years of probation and a 100,000 dollar fine, and the company five years of probation and a 250,000 dollar fine. Another firm was fined 250,000 dollars over more than 63,000 pounds of foreign lobster and thousands of pounds of shark fins falsely labelled as domestic. By the agency’s own account, both were surfaced through import monitoring data rather than by anyone opening a box.

Notice what those cases have in common with the salmon one. Nobody was caught by inspection at the point of sale. Nobody spotted the fish. In every instance the fraud was visible only in the documents, because the documents are the only place where a lie about origin has to be written down and kept. A forged provenance is evidence in a way that a fillet never can be, which is the quiet reason paperwork requirements matter even when compliance with them is patchy and the audit rate is close to nothing.

There is a fair objection to raise here, and it deserves an airing rather than a brush-off. Nobody was poisoned. Chilean farmed salmon is a perfectly ordinary food product, sold openly and eaten by millions of people who are happy with it. If a diner ate it thinking it came from somewhere else and enjoyed the meal, what exactly was the harm?

Two things, and they are both real.

The first is that people were charged for something they did not receive. Everyone in that chain, the restaurant, the retailer, the person at the table, paid a premium attached to a specific claim, and the claim was false. That is the ordinary definition of fraud, and it does not become less true because the substitute was edible.

The second is bigger, and it is the reason a wildlife statute rather than a trading standards rule was the tool for the job. Country of origin labelling is the load-bearing wall of nearly every attempt to make seafood more sustainable. Every certification scheme, every fishery improvement project, every consumer guide telling you which fish to choose, every import restriction aimed at a fleet with a bad record, all of it depends on knowing where a fish actually came from. A buyer who pays more for salmon from a place with tighter environmental rules is trying to send money to that place. If origin can be rewritten on the box for a couple of hundred thousand dollars, the entire signalling mechanism stops working, and the careful buyer’s money ends up somewhere they never chose.

That is not an argument about Chilean salmon, which was never the problem. It is an argument about whether any of the labels mean anything, and about what happens to the people who took them seriously.

The wholesaler, for its part, has taken the penalty, is under court supervision for three years, has to operate a compliance programme that will be checked, and is running under new leadership. That is a real and proportionate outcome for a company that admitted what it did. Nobody went to prison, because no individual was charged, and it would be wrong to imply otherwise.

The part of this that is likely to matter longest has nothing to do with one business in Texas. It is that origin has stopped being a claim and started becoming a measurement. For the whole history of the seafood trade, where a fish came from was something you took someone’s word for, and the only enforcement was reputational. Now there are genetic reference libraries, isotope signatures, chain of custody filings and a federal statute originally written for feathered hats sitting behind the claim on the box.

The gaps in that system are still wide enough to drive a two-year scheme through, and salmon is not even inside the main programme. But the direction is one way. A label that used to be unfalsifiable is becoming checkable, and once something is checkable, someone eventually checks.

In this instance somebody did, and the box on the pallet turned out to have been telling a story about a country its contents had never seen.

A man in New York bought four tickets to a soccer match. The tickets cost him about 131 dollars. The fees cost him another 76. That is not a rounding error on a night out, that is more than half again on top of the thing he actually wanted, added at the end, after he had already decided to buy.

So he did what people almost never do about a fee. He sued.

And a federal judge has now ordered that lawsuit out of the public court system entirely, into private arbitration, one claimant at a time, with no class, no jury and no public record of how it ends. The order arrived on a single page.

The buyer is Louis Sanquini, and his case is one of those small stories that turns out to be about something much larger than the sum involved. Because the money is not really the point. The point is a paragraph he agreed to without reading it, which almost everyone reading this has also agreed to, probably several times, probably this year.

What Sanquini actually alleged is worth getting right, because a lot of the coverage flattened it into a story about ticket fees and it is not quite that. His complaint, filed in the Southern District of New York last summer, centred on something that had come to light through a Canadian broadcaster’s investigation: that StubHub’s chief executive, Eric Baker, holds a financial stake in a fund that resells tickets in bulk on StubHub itself.

The fund is called Andro Capital. According to the complaint, Baker owns part of it and has served as a managing director there, and the company’s own securities filings show StubHub paying fees to Andro and covering ticket management costs, along with arrangements with an affiliate, Colloquy Capital, for short-term financing and for referrals to other large professional resellers.

The allegation that follows from that is simple enough to state in one sentence. Buyers thought they were on a marketplace where fans sell tickets to other fans, and the people running the marketplace had a direct financial interest in the professional operations supplying a great deal of the inventory. The proposed class action put the figure it was seeking at around 5 million dollars. StubHub and Baker did not respond to press requests for comment when the suit was filed.

That is the case that has just been sent into a private room.

The judge is Jed Rakoff, who has sat on the Southern District bench since the mid-1990s and took senior status more than a decade ago, and who built a reputation as one of the federal judiciary’s least deferential figures when it comes to corporate settlements he thinks are too soft. He heard oral argument, and days later he granted StubHub’s motion to compel arbitration, stayed the court case while arbitration runs, and denied the motion to dismiss as moot, which leaves the company free to raise dismissal again later. He said a fuller opinion explaining his reasoning would follow.

Rakoff is an interesting judge to have signed this particular order, which is part of why it landed the way it did in the industry press. He spent years as a federal prosecutor handling business and securities fraud before going to the bench, and he became widely known for refusing to rubber stamp settlements between regulators and large companies when he thought the public was being asked to accept a deal without being told what actually happened. Judges with that instinct do not usually enjoy sending a disclosure case into a confidential forum. The likeliest explanation for the one page order, and for the promise of a longer opinion to follow, is that he considered the question of enforceability a narrow one and the answer legally unavoidable, and wants to explain at length why.

The instrument that did the work is the Global User Agreement, the terms a buyer accepts to finish a checkout. It says claims go to binding and final arbitration. It says claims may be brought only individually. It says class actions are off the table. In the parallel case we will come to in a moment, the relevant passage was in bold capital letters, which is the part people find hardest to believe afterwards. It was not hidden in six point grey type. It was shouted. Nobody read it anyway.

There is also an escape hatch, and it is real. A buyer can opt out of the arbitration clause by mailing written notice within 30 days of accepting the terms. Thirty days, by post, over a checkbox you did not notice you had ticked. Almost nobody does it. That is not an accident of drafting. It is the design working as intended.

To understand why a clause like that is so powerful, it helps to know where it came from, because consumer contracts did not always look like this. The turning point was a Supreme Court decision more than a decade ago involving a mobile phone company and a dispute over a charge on a supposedly free handset. The court held that federal arbitration law overrides state rules that would have treated bans on class actions in consumer contracts as unenforceable. After that ruling, the class action waiver stopped being a legal gamble and became standard equipment. It spread through phone contracts, banking, streaming, ride hailing, food delivery and ticketing, until it was easier to list the services that did not have one.

And the economics of it are brutal in a very specific way. Seventy-six dollars is a genuine irritation and a completely unrecoverable loss. No lawyer takes that case. No individual spends a year of evenings on it. Multiply it by every buyer on a platform that moves millions of tickets and the same 76 dollars becomes a number that would make a board of directors sit up straight. The class action exists precisely to bridge that gap, to let a harm that is trivial one at a time and enormous in aggregate be heard as the single thing it actually is. Remove the class and the aggregate simply disappears. The grievance does not stop existing. It stops being expressible.

Lawyers noticed this, and in the last several years they built a counterweight that companies did not see coming. If claims must be individual, then file them individually, tens of thousands at once, each one triggering a filing fee the company has to pay before an arbitrator will even look at it. Mass arbitration turned the class waiver into a liability. Suddenly the private forum that was supposed to be cheap became the most expensive room in the building.

Which is where the ticketing industry produced the cautionary tale. Live Nation and Ticketmaster rewrote their terms to route disputes to a small arbitration provider under a protocol built for volume. Claims would be batched. A handful of bellwether cases would be decided, and those outcomes would then be applied to other claimants who had no chance to participate in them. Discovery and briefing were tightly limited, appeal rights were narrow, and the provider itself controlled the selection of arbitrators.

A federal appeals court looked at that arrangement and refused to enforce it, finding it unconscionable both in how it was imposed and in what it actually did. The court described terms of adhesion with misleading language, and objected in particular to bellwether decisions binding people who never took part in them. The motion to compel arbitration failed, and the underlying ticket fee litigation was allowed to go forward in open court. Related fights over the same clause have continued through the appellate system since, including in a federal appeals court on the east coast and in a state supreme court out west.

It is worth being concrete about what the private room actually is, because arbitration is often described as if it were simply a smaller, friendlier courtroom. It is not. A single arbitrator, usually a retired judge or a practising lawyer, hears the matter under the rules of whichever provider the contract names. There is no jury. Discovery is narrower, which matters enormously in a case built on what a company knew and disclosed internally. The proceeding is confidential by default, so the filings, the evidence and the reasoning stay out of public view. Appeal rights are close to nonexistent, since courts will overturn an award only in a very short list of circumstances. Companies typically cover the arbitrator’s fees in consumer cases, which sounds generous until you notice that the person paying the arbitrator is also the party most likely to appear before that same arbitrator again.

So the two companies ended up in opposite positions on the same question, and the difference was not luck. Live Nation lost because it got greedy with the machinery, building a process so tilted that a court could see the tilt from across the room. StubHub’s clause is comparatively plain. Individual claims only. Standard arbitration. A real, if impractical, opt out. Plain wins.

There is a second StubHub case worth putting beside this one, because it shows the clause operating on a completely different kind of complaint and producing exactly the same result. A buyer named Alexis Christensen spent roughly 14,000 dollars on three premium seats for the closing night of Taylor Swift’s Eras Tour in Vancouver, about 4,670 dollars a ticket. When she arrived, she was told the seats were not available. What she was given instead were seats reportedly worth around 1,200 dollars each. She argued the company had broken its own buyer guarantee.

A federal judge in Washington state ordered that dispute into arbitration too. She had not opted out within the 30 days. The bolded capital letters had done their job.

One case is about a fee of 76 dollars on a soccer match. The other is about roughly ten thousand dollars of value that allegedly evaporated at a stadium door. Same clause, same door, same outcome.

None of this is happening in a vacuum, which is the part that makes the arbitration order sting. Earlier in the year, the United States Federal Trade Commission announced that StubHub would refund about 10 million dollars to consumers over how it displayed prices. The agency’s fees rule, which took effect the previous year, requires the total price including mandatory fees to be shown up front. Regulators found the company had advertised prices without those fees across the first three pricing displays on its site, leaving buyers to discover the real number later in the purchase flow. The refunds covered purchases made in a narrow window after the rule came into force, and the order required the company to show total prices clearly and prominently going forward. The consumer protection director’s framing was that price transparency is what makes a competitive market work at all.

These are two separate matters and they should not be blended. The regulator’s action was about how prices were displayed. Sanquini’s suit is about who was allegedly selling. But taken together they describe a buyer who had grounds to feel misled on two different fronts, and who has now been told that one of those fronts is not a matter for a court.

Lawmakers have been circling the same questions. Last summer, Democrats on the House Oversight Committee wrote to Baker asking whether his outside ticket reselling interests had effectively let him manipulate the market he also runs, and set a deadline of a few weeks for answers. A congressional letter is not a subpoena and not a finding, and it is worth keeping the distinction, but it does mean the underlying allegation is being examined somewhere other than a private arbitration.

So what actually happens to Louis Sanquini now.

His claim is not dead. That is the thing people get wrong about these orders. He can still bring it, and an arbitrator can still find in his favour and order his 76 dollars back, and if that happens he will have won. What he cannot do is bring it on behalf of everyone else who paid the same fees under the same allegedly undisclosed arrangement. There will be no certified class, no discovery record made public, no reasoned decision that any other buyer can pick up and point to. Arbitration awards are not precedent. Mostly they are not even visible. The case does not lose, exactly. It goes quiet.

Rakoff has said a full opinion is coming, and that opinion will matter, because it will set out on the record how a judge who is famously unimpressed by corporate convenience nonetheless concluded that this particular clause had to be enforced. The answer, almost certainly, will be that the law left him very little room. Whether the plaintiffs appeal has not been decided.

And the practical residue of all this, the piece worth carrying out of it, is the opt out. It is genuinely there, in the StubHub terms and in a great many others. Thirty days, in writing, and you keep your right to go to court with everybody else who was treated the same way. It is deliberately inconvenient, and it takes about ten minutes, and it is the only part of this whole arrangement that is actually in the buyer’s hands.

The fee was 76 dollars. The thing that was really being sold at that checkout was the right to argue about it in public, and it went for free.

When Sam Neill sat down in front of a television camera and said he was not remotely afraid of dying, nobody quite knew where to put it. He was a famously private man in the middle of treatment for an aggressive blood cancer, and the expected script was either brave silence or a carefully managed statement. Instead he said the thing out loud, added that he found the whole business more annoying than frightening because he still had things he wanted to get on with, and then went back to work.

He died in July, in Sydney, at 78. His family said the death was sudden and unexpected, that he was surrounded by them, and that he had remained cancer free. No cause was given. A co-star said afterwards that he had been dealing with pneumonia in the period beforehand, though that account came from a friend rather than the family, and it has never been formally confirmed.

What follows is not really a filmography, although the filmography is enormous and strange and worth walking through. It is the story of a man who, given a diagnosis that most people would have hidden, decided that hiding it would be worse. He talked about it. He wrote a book while it was happening. He posted pictures of his ducks. He kept planting vines. And in doing so he rearranged, quietly and without any speeches about it, what a famous person is allowed to say about being ill.

He was born in Omagh, in Northern Ireland, in the years just after the war, and his parents took him to New Zealand when he was about seven. His given name was Nigel. He picked up Sam at school, on the reasonable grounds that Nigel was not a name that survived a playground, and it stuck for the rest of his life. He studied English literature and took a degree in 1970, and then went into an industry that in New Zealand at the time barely existed. There was no local film business to speak of. There were documentaries, government work, and a handful of people convinced that a country of three million could make its own pictures.

His breakthrough came in the late seventies with a New Zealand thriller called Sleeping Dogs, a film about an ordinary man who wants nothing to do with politics and finds that politics has no intention of leaving him alone. It is not the kind of film that usually launches an international career. It launched his. Within two years he was in My Brilliant Career, the Australian period drama that made Judy Davis a star and put Neill in front of an audience that had never heard of him.

It helps to understand how small that world was. New Zealand in the seventies had a government film unit that made documentaries and public information reels, and almost nothing else. There was no studio, no established path, no reason to believe a career was possible without leaving. Neill worked in that environment, directing and appearing in documentary work before features arrived, and the generation he belonged to effectively built the industry by insisting on making things until making things became normal. Everything that came afterwards, including the trilogies that now shoot there, sits on top of that decade.

Then something unusual happened, which is that he refused to become one thing. The obvious move after My Brilliant Career was the handsome leading man in respectable literary adaptations for the next thirty years. He did some of that. He also took the role of the Antichrist in the third Omen film, which is not a respectable choice by any measure, and in the same year appeared in Possession, a film so unhinged and so uncategorisable that people still argue about what it is actually about. He played a spy in Reilly, Ace of Spies and got his first Golden Globe nomination for it. He played a husband slowly realising that the man who has boarded his yacht in the middle of the Pacific is not what he seems, in Dead Calm, opposite a very young Nicole Kidman.

And then, in a single year in the early nineties, he appeared in both Jurassic Park and The Piano, which is one of the odder doubles in modern cinema. One was the biggest film in the world, a dinosaur picture that reset what audiences expected a special effect to look like. The other was a quiet, brutal, prize-winning drama about a mute woman, a piano and two men, in which Neill played the husband, which is to say the least sympathetic part in the film and the hardest one to make human. He made it human. People remember Alan Grant, the paleontologist in the wide-brimmed hat who cannot work a seatbelt and cannot stand children until he is responsible for two of them. Fewer people notice that the same actor, in the same twelve months, did the other thing entirely.

He kept going like that. Horror in Event Horizon, a film that failed on release and then refused to die, the way a certain kind of film sometimes does, and is now discussed with real seriousness. Fantasy in Merlin, which brought him an Emmy nomination. Later, television found him again and again, in The Tudors, in Peaky Blinders as a detective with a voice that could strip paint, in a streaming mystery series in his final years. Three Golden Globe nominations, two Emmy nominations, more than fifty years of work, and no obvious through line except that he was interesting in everything and never once seemed to be trying to impress you.

Off screen he did something that made more sense to him than any of it. In Central Otago, in the deep south of New Zealand, he bought land and planted pinot noir. The vineyard was called Two Paddocks, and it began as the sort of hobby that famous people take up and abandon, and became instead a working business that he ran with visible seriousness for decades. He named blocks after things he cared about. He kept animals. He gave them names and personalities and, in his later years, an enormous online following, because he started posting videos of himself walking around his property introducing his ducks, his pigs and his cattle to several hundred thousand strangers.

This is the part that matters for what came later. By the time he got ill, he had already spent years being a specific kind of public person: dry, self-deprecating, allergic to grandeur, more likely to talk about a difficult harvest than about a film premiere. He had built an audience that knew him as a man with muddy boots rather than as a movie star. When he needed to tell them something serious, he had a way of speaking to them that already existed.

The diagnosis came in early 2022. He noticed that his glands were swollen. What the tests found was angioimmunoblastic T-cell lymphoma, a rare cancer of the immune system’s own T cells, and it was found at stage three. The first round of chemotherapy did what chemotherapy is supposed to do, and then it stopped doing it. The cancer became resistant and, by his own account, came back more aggressive than before. He was moved onto a newer treatment, still relatively experimental at the time, and it worked. He went into remission and stayed there.

It is worth saying what that disease actually is, because the name is forbidding and the reality is more specific. Angioimmunoblastic T-cell lymphoma is a rare cancer that begins in the T cells, the part of the immune system whose job is to recognise threats. When those cells turn, the machinery that protects the body starts producing the problem instead, which is why the illness often announces itself through swollen glands, rashes and fevers rather than anything that looks like a tumour. It accounts for a small fraction of lymphoma cases worldwide, it tends to be diagnosed late because the early signs look like ordinary illness, and the treatment outlook has improved substantially in recent years. Neill was a beneficiary of that improvement. Ten years earlier the newer drug that put him into remission would not have been available to him.

He did not announce any of this while it was happening. He announced it about a year later, when a memoir he had written appeared, and the memoir was the reason he had to. He had started writing it because he was not sure how long he had. That was the whole motivation. He wanted his children and his grandchildren to have the stories, the jokes, the accounts of bad decisions and good ones, in his own voice rather than someone else’s. He described it as running against the clock. He wrote during treatment, on days when he felt capable, and he said later that the book had given him something to do with the part of his mind that would otherwise have been busy with the diagnosis.

The book, which took its title from the thing he apparently said constantly at dinner tables, was not a misery memoir and was not a recovery narrative. It was a raconteur’s book. It was funny about famous people without being unkind about them, and funny about himself without fishing for reassurance. The cancer was in it, because it would have been dishonest to leave it out, but it did not run the book.

Then came the interviews, and the sentence that ended up in every headline. He said he was not remotely afraid of dying. He said what bothered him was the idea of not being around, of missing what came next, of the things he had not done yet. He said he found the prospect irritating rather than terrifying. People with his diagnosis wrote to him. People with completely different diagnoses wrote to him. What they kept saying was that hearing someone say it plainly, without either false cheer or a soundtrack, had made the thing smaller.

There is a reason that landed. The standard public language around serious illness had spent decades getting steadily more heroic and steadily less useful. People fight, they battle, they are warriors, they are brave. It is a vocabulary that turns getting better into winning and getting worse into losing, which is cruel to anyone who does not get better and is not how any of it actually works. Neill would not use it. He was not fighting anything. He was having treatment, some of which worked and some of which did not, while continuing to do the things he liked doing, which were acting and making wine and annoying his dog. He talked about it the way you would talk about a persistent and inconvenient guest.

He also kept working, which is its own statement. He did not retire to be ill. He filmed a series, went to press events, walked red carpets, and looked, in the photographs, like a man who was entirely aware of how he looked and had decided it did not require an explanation. He spoke about chemotherapy having taken his hair and about finding the whole thing undignified in ways nobody warns you about. He was completely uninterested in being inspirational. That, more than anything, was why people found him inspiring.

His remission held. When he died, his family were specific about that, saying he had remained cancer free, and specific too that the death was sudden and unexpected. There is a strange kind of mercy in that detail and also a strange cruelty. He had spent four years being open about a disease that was widely expected to kill him, had beaten it back, had told everyone he was not afraid, and then died of something else entirely, quickly, with his family around him. The statement said he passed with the dignity that had characterised his whole life, and for once that sort of line in a family statement read as accurate rather than obligatory.

The tributes came from the places you would expect and from some you would not. New Zealand’s prime minister said he had taken the country’s stories to the world, which is true in a way that goes beyond the obvious. Neill had spent his career being an ambassador for an industry that did not exist when he entered it and is now one of the most significant production centres on the planet. He had been knighted a few years before his death for services to film. He took the knighthood, and then mostly declined to use the title, because using it would have required a version of himself he had never been interested in.

Actors who had worked with him said the same handful of things, which is usually a sign that they are true. He learned everyone’s name. He was funny on set in a way that made long days shorter. He was generous with younger actors in scenes where he could easily have taken the oxygen. Several of them mentioned the wine, which he sent to people, unprompted, for years.

He left four children and eight grandchildren, a vineyard that will go on producing under his name, and a body of work that will be discovered in the wrong order by people who have no idea that the man in the dinosaur film and the man in the art-house drama are the same person. That has always been the fate of a genuinely versatile actor. You do not get a single defining image. You get a shelf.

But the thing he will be remembered for outside cinema is smaller and harder to film. He took a diagnosis that most people treat as a private catastrophe and made it something he could talk about at ordinary volume. He did not turn it into a cause. He did not raise a flag. He simply refused to perform either courage or despair, and in refusing, he gave a great many frightened people a script they could actually use.

He said he was not remotely afraid. The remarkable part is not that he said it. Plenty of people say it. The remarkable part is that everything he did for the next four years, the book, the vines, the ducks, the work, the jokes at his own expense, looked exactly like the behaviour of a man who meant it.

Somewhere in a British cinema this week, an usher is going to have to make a decision about a pair of spectacles, and there is no honest way for that usher to get it right.

The glasses on the person’s face might be ordinary prescription lenses. They might be a camera capable of recording the entire film in high definition without anybody in the row noticing. They might be an assistive device that is the only reason that customer can follow the dialogue at all. In a darkened auditorium, standing at the end of an aisle, looking at a stranger who has paid for a ticket, the usher cannot tell the difference. Nobody can.

That is the problem the UK Cinema Association has just admitted it does not know how to solve. The association represents the operators behind the overwhelming majority of cinema screens in Britain, and in guidance to its members it acknowledged that many of them are now introducing policies to prohibit or restrict the wearing of camera-enabled smart glasses in their venues. In the same breath it conceded that operators recognise these devices can genuinely help customers with access requirements, and that the whole question is, in its own careful phrasing, clearly a developing area. Having said that much, the association said it would make no further comment for now.

Read that carefully and you can see an industry working out loud. Cinemas have two commitments here and the technology has put them directly into conflict. One commitment is to the studios, which insist that the auditorium is the last secure room in the film business, where recording is not merely against the house rules but a criminal matter. The other commitment is to the several million customers who cannot fully use a cinema without help, and who have spent decades asking the industry to take their access seriously. A blanket ban on smart eyewear honours the first commitment by breaking the second.

What makes this worth paying attention to is that Britain already tried this once, and the man who announced it then is the same man in charge now. Back in 2014, when Google Glass launched in the UK, the trade body then known as the Cinema Exhibitors Association asked customers not to wear wearable recording technology in auditoriums, with staff empowered to ask anyone who did to take them off or leave. Its chief executive, Phil Clapp, explained the reasoning at the time in language that has aged almost too well. Phones can be put away when the film starts. With something you wear, he said, it is generally harder to know when it is recording and when it is not.

Britain was not even first. An American cinema chain known for its strict rules about talking and texting had banned the devices a few weeks earlier on the same reasoning, and casinos, bars and restaurants across the United States were doing the same. For a brief period the wearable camera looked like a settled social question that had been answered no.

That policy went precisely nowhere, for the simple reason that Google Glass went precisely nowhere. Nobody had to enforce a rule against a product that almost nobody bought and that anyone wearing in public was instantly, conspicuously identifiable as wearing. The device announced itself. It sat above the eyeline on a titanium band with a visible prism hanging in front of one eye, and people who wore them acquired a nickname that ended their social viability faster than any cinema policy could.

What has changed in the intervening years is not the rule and not the anxiety. It is the industrial design. The current generation of camera glasses do not look like technology. They look like Wayfarers, because a very large number of them are Wayfarers, built in partnership between Meta and the eyewear conglomerate that owns Ray-Ban. The second-generation Ray-Ban Meta glasses carry a twelve megapixel camera, on-board microphones, live streaming, and a voice assistant, inside a frame that is visually indistinguishable at two metres from a pair of sunglasses somebody has owned since university. Last year Meta went further and announced a version with an actual display built into the lens, controlled by a wristband that reads the small electrical signals in your forearm, so the wearer can operate the thing without moving a hand that anyone would notice. It went on sale at around eight hundred dollars.

The scale is the part that makes this different from the last time. The eyewear group that manufactures the frames reported selling around seven million smart glasses in a single recent year across its Ray-Ban and Oakley lines, after reaching only two million cumulative units in the first year or so on sale. It has talked about pushing annual production capacity toward ten million, and there have been reports of discussions about going considerably higher than that. Google Glass never sold in numbers anyone bothered to publish. These are mass-market sunglasses that happen to contain a camera, bought overwhelmingly by people with no interest whatsoever in recording a film, and that is exactly why a cinema cannot treat their presence as suspicious.

There is a safeguard, and it is the thin thread the entire consent argument hangs from. A small white LED on the frame lights up when the camera is running. In a bright room, at conversational distance, from the correct angle, it works. Privacy researchers have pointed out for years that it is far less reliable in low light, which is a polite way of describing the exact conditions inside a cinema, and there has been a small aftermarket in modifications that disable the light altogether for a few dollars. A safeguard that costs sixty dollars to remove is not really a safeguard. It is a courtesy extended by people who were never the problem.

The privacy half of this story arrived before the piracy half did. The glasses picked up an ugly nickname online after reports of men using them to film women without consent and post the footage, in some cases attached to enough personal detail that the women involved were then harassed. That is not a cinema problem specifically. It is a public space problem, and cinemas simply happen to be a dark public space where people sit still for two hours next to strangers. The industry did not ask to become the test case, but it is a reasonable place for the argument to land, because a cinema is one of the last places where an audience genuinely cannot see what is happening around them.

The piracy half is where the money is, and where the numbers get slippery. The film industry has argued for a very long time that the great majority of pirated copies in circulation originate from somebody recording a screen inside a theatre, a claim that has been repeated so often it is now treated as settled fact and that independent researchers have never been able to verify at the stated level. What is not in dispute is that camcorded copies are the first copies. A film that leaks on its opening weekend leaks from a room with a screen in it, and everything downstream flows from that single recording. British cinemas have run anti-camcording training for staff for years, with reward schemes for employees who spot a recording in progress, and every one of those programmes assumes an object the staff member can see. A phone held up. A camera bag on a lap. A red standby light in the back row.

The economics behind all of it are brutally simple. A film earns most of what it will ever earn from cinemas in its first two or three weekends, and the value of that window collapses the moment a watchable copy is available for nothing. It does not need to be a good copy. A shaky recording with heads in the bottom of the frame and muffled sound is enough to satisfy a meaningful number of people who were never going to pay, and enough to satisfy some who would have. Every additional week a distributor can keep a clean copy off the internet is money, which is why the studios treat the auditorium the way a bank treats a vault.

None of that training survives a pair of glasses. The whole apparatus of cinema anti-piracy enforcement depends on a recording device looking like a recording device, and that assumption has now quietly stopped being true.

Which brings us back to the person in row F, and to the part of this story that most of the coverage skipped. Cinemas have spent the better part of two decades putting glasses on people’s faces on purpose. When the industry finally took accessibility seriously, one of the answers it reached for was eyewear. Captioning glasses, developed by Sony and rolled out across thousands of screens, display subtitles that float in the wearer’s field of view while the screen itself stays clean, so a deaf or hard of hearing customer can go to any showing at any time rather than the one subtitled screening at eleven in the morning on a Tuesday that nobody else wants to attend. That was a genuine advance, and it was achieved with a pair of glasses with a display in them.

The modern devices do the same job better and do other jobs besides. Meta has argued publicly that its glasses are critical technology for blind and low vision users, and that restricting them would be a significant step backwards. It would be easy to dismiss that as a company defending its product, and partly it is, but the underlying point is not wrong. An AI assistant that can describe your surroundings out loud, read text to you, and answer a whispered question is a meaningful improvement in independence for someone who has spent their life asking other people to read things to them. Somebody who relies on that does not switch it off at the cinema door because it is inconvenient for the studios.

So the door staff are being asked to do something genuinely impossible. They must distinguish, in low light, at speed, without embarrassing anybody, between a device that threatens a distributor’s release window and a device that is the reason a customer can attend at all, when the two devices are frequently the same device being used for different purposes. The obvious answers all fail. Banning everything punishes disabled customers for the behaviour of pirates. Allowing everything leaves a hole in the one security perimeter the film industry has left. Asking people to declare their disability at a ticket desk in order to keep their glasses on is the kind of policy that sounds reasonable in a meeting and humiliating in practice, and access campaigners have spent years explaining why.

There is no national rule in Britain, and that is a deliberate choice rather than an oversight. The association has not mandated anything. Individual operators are writing their own policies, which means the answer to whether you can wear your glasses depends entirely on which company’s building you walk into, and in some cases on which member of staff is on the door. Cinemas are not alone in this. Courts in England and Wales have restricted the devices, as have courts in New York state, and Germany’s data protection authority has suggested there are legal grounds for banning them in certain settings. In the United States, the major theatre chains were asked directly what their policies were and had not answered publicly, which is its own kind of answer.

The most likely outcome is not a ban at all. It is the same thing that happened with phones, which is to say the industry will eventually stop trying to keep the device out of the room and start trying to make the recording useless once it leaves. Cinemas already run forensic watermarking on digital prints, invisible markers baked into the projected image that let a distributor trace a leaked copy back to a specific screen and a specific showing. That technology does not care what recorded it. Glasses, phone, professional camera, the watermark survives all of them, and it turns a detection problem the staff cannot win into an evidence problem the studios can.

In the meantime, the honest position is the one the trade body took, which is to admit the thing is unresolved rather than pretend otherwise. That is unusual and worth noting. It would have been much easier to issue a firm-sounding ban, generate a day of supportive headlines about protecting films, and quietly leave the enforcement problem with the lowest-paid person in the building. Instead the industry said out loud that it has two duties here, that they point in opposite directions, and that it has not worked out the answer yet.

Twelve years ago the same organisation, under a different name and the same chief executive, wrote a rule about glasses and never had to enforce it, because the glasses failed. This time the glasses are selling, and they look like glasses, and the rule will have to mean something. Somebody is going to have to decide what happens in row F, and for once the people responsible have admitted they do not yet know.

For eleven years, Netflix put films into cinemas and then declined, politely and consistently, to say how they did. Not vaguely. Not with a rounded figure. Nothing at all. Rival studios published their weekend grosses every Sunday morning like clockwork, the trade press built an entire ritual around the numbers, and Netflix simply stood outside the ritual and said the number was not the point. Now it has changed its mind on six films, and the interesting question is not why it stopped hiding the number. It is what happened to make the number worth showing.

The announcement landed a few weeks ago and it is narrower than the headlines suggested. Netflix confirmed it will publicly report box office grosses on six upcoming titles: a Spanish-language epic called La Bola Negra from the directing pair Javier Ambrossi and Javier Calvo, The Further Mis-Adventures of Cliff Booth, The Mosquito Bowl, a Danny Boyle picture called Ink, Greta Gerwig’s Narnia: The Magician’s Nephew, and an animated Charlie vs. the Chocolate Factory. Six films. Not the slate. Everything else the company sends into cinemas, and it sends a fair amount, still goes out with no gross attached and no plan to attach one.

That partial quality is the whole story. A company that genuinely converted to transparency would report everything. A company that has decided a specific set of numbers now helps its argument reports exactly those numbers, and Netflix has always been unusually clear-eyed about which numbers help it.

To understand how strange this reversal is, you have to go back to where the policy started. Netflix’s first real theatrical release went out in autumn 2015, a war drama shot in West Africa, released in a small number of cinemas on the same day it appeared on the service. The major chains refused to carry it because it broke the exclusivity window they considered non-negotiable, so it played in independents and arthouses and made an amount of money that was, by studio standards, close to nothing. Reporters asked for the figure. Netflix declined, and instead announced that three million people had watched it at home in its first days.

That was the opening move of a philosophy the company stuck to for over a decade. Box office, in this telling, measures how many people bought a ticket to a specific building on a specific weekend, which is an interesting fact about the twentieth century and a poor measure of how many people saw a film. Netflix had a better number, or at least a bigger one, and no obligation to publish either. It was also, quietly, a defensive position. If you do not report, you cannot be reported as having flopped.

For years the policy held under real pressure. The company put some of the most expensive and most decorated films of the era into limited theatrical runs purely to qualify for awards, and in every case the grosses stayed private. Cinema owners hated it. Rival executives found it faintly insulting. Analysts built estimates out of ticketing-site scrapes and guesswork. Netflix kept saying the same thing in slightly different words, which was that theatrical release was a service it performed for filmmakers and for awards eligibility, not a business it was in.

Then something happened that made the position much harder to hold, and it happened by accident.

Last year Netflix put an animated musical it had already released on the service back into cinemas for a weekend, as a sing-along event. There was no serious marketing campaign behind it, no exclusivity, nothing on the line. The film was already free to anyone with a subscription. It went to number one in North America anyway, the first time a Netflix film had ever topped a weekend, with third-party estimates putting it somewhere in the region of 18 to 20 million dollars across two days.

Netflix declined to report the figure.

Think about that for a moment. The company finally had the thing it had spent a decade saying it did not care about, the number one slot, and its own policy meant the number had to come from other people’s estimates. It was beaten on its own weekend by arithmetic done by outsiders. Trade reporters noted the absurdity with obvious enjoyment. The policy that had been designed to prevent embarrassment had produced a new kind of embarrassment, one where the company could not take credit for a win because it had spent eleven years arguing the win did not exist.

That weekend is not the official reason for the change. Netflix has not given an official reason beyond confirming the plan. But it is very hard to look at the sequence and not see cause and effect.

The other thing that changed is the size of what Netflix is now putting into cinemas, and the length of time it is leaving them there. La Bola Negra, a Cannes-decorated Spanish-language film with serious awards ambitions, is getting a theatrical run of roughly 47 days before it reaches the service, which is the longest gap Netflix has ever allowed between a cinema release and a streaming release. For most of the company’s history, the gap was measured in days, sometimes in hours. A month and a half is a conventional studio window. It is the kind of window cinema owners have been demanding from Netflix since 2015 and being refused.

Cliff Booth, the David Fincher film continuing the story of a character from a Quentin Tarantino picture, is getting a two-week exclusive run on giant-format screens over the American Thanksgiving holiday, which is one of the two or three most valuable release corridors in the calendar. You do not put a film there to satisfy an awards technicality. You put it there because you want the money.

And then there is Narnia, which is the clearest signal of the lot, and where the story has moved more than most coverage has caught up with.

The plan for Greta Gerwig’s adaptation of The Magician’s Nephew was originally an exclusive giant-format run in late 2026 followed by a streaming release a month later. That plan changed. Reporting attributes the shift partly to a production delay, but the replacement plan is far more ambitious than the original: a full worldwide theatrical release in early 2027, in ordinary cinemas as well as giant-format ones, with preview screenings on around a thousand large-format screens two days ahead of the wide opening, and a gap of roughly seven weeks before it arrives on the service. International distribution in most territories is being handled by a traditional studio’s releasing arm rather than by Netflix itself.

That is not a company performing a theatrical release. That is a company doing one, in the ordinary sense, for the first time. Which means Cliff Booth, not Narnia, is the film taking the giant-format slot that Narnia was going to occupy, and Narnia has been upgraded rather than converted into an experiment.

It is worth remembering how bitter the fight over that gap used to be. For most of the last decade the major cinema chains held a simple line: a film gets a period of weeks in which cinemas are the only place to see it, or the chains will not carry it. Netflix refused, on the grounds that asking a subscriber to wait ninety days for a film they were already paying for was an insult dressed up as tradition. Whole films were effectively locked out of the biggest chains as a result. Directors who wanted both the Netflix budget and the big screen had to choose. The pandemic shortened the standard window for everyone, and the gap most studios now use has settled somewhere around six or seven weeks, which is very close to what Netflix has just agreed to on its two biggest upcoming titles. The argument did not end with either side winning. It ended with both sides quietly moving to roughly the same number and declining to say so.

Once you are releasing films that way, the refusal to report grosses stops being a principled stand and starts being a liability. Cinema owners program their screens weeks ahead based on what they think will sell. A film with no published performance history is a film a booker cannot reason about. Marketing partners want the number. Awards campaigners want the number, because a Spanish-language film with a serious Best Picture ambition is helped enormously by evidence that audiences turned up for it rather than merely that a streaming service says they did. And filmmakers, who are the people Netflix is competing for hardest of all, want the number most of all, because it is the currency their whole profession uses to keep score.

That last point deserves more weight than it usually gets. Netflix has spent a decade persuading directors who grew up in cinemas that a film released on a service is a real film. The money helped. The creative freedom helped. But every director who signed knew that when the film came out, there would be no Sunday morning when their peers saw a number next to their name. For a certain kind of filmmaker that absence is not a relief, it is a void. Reporting grosses on six films is, among other things, a recruitment pitch.

There is a reading of all this that is less flattering and probably also true. Netflix’s subscriber growth has slowed in its mature markets, and the company stopped reporting quarterly subscriber numbers entirely a couple of years ago, which tells you something about how it handles metrics that have stopped flattering it. When one number stops being an argument in your favour, you look for another. Theatrical grosses, on six carefully chosen films with real windows and real marketing behind them, are a number Netflix can now expect to look good. It is not hypocrisy exactly. It is a company that has always understood that a published figure is a piece of rhetoric, and has simply changed which rhetoric it wants.

The exhibition industry’s reaction has been a kind of guarded delight. Cinema owners have spent eleven years treating Netflix as the adversary, the company that wanted to collapse the window and had the cash to do it. The head of the main North American exhibitors’ body appeared publicly alongside Netflix’s co-chief executive around the announcement, which would have been unthinkable a few years ago. One veteran distributor, speaking anonymously to the trade press, put it plainly: exhibitors would welcome this, because the prospect of Netflix throwing its marketing weight behind a genuine theatrical campaign is worth more to a cinema than any argument about principle.

What nobody in that industry is saying out loud is that the welcome is conditional and slightly nervous. Six films with reported grosses is six films Netflix can point to when it wants leverage. If the numbers are strong, Netflix has evidence that it can do theatrical on its own terms and does not need the traditional window to do it. If the numbers are weak, Netflix has evidence that theatrical is not worth the trouble and can go back to saying so with data instead of philosophy. Either result strengthens the company’s hand. That is what a well-chosen metric does.

There are also things this change does not do, and they matter. Netflix has not committed to reporting grosses on anything beyond these six. The many films it will continue to put into token theatrical runs for awards purposes will still go out into silence. There is no published detail on exactly what will be reported, whether it will be a full Sunday estimate in the standard format that every other studio files, or a cumulative figure released when the company chooses. The difference is not trivial. Reporting a weekend estimate on a Sunday morning means accepting public comparison with everyone else’s film in real time. Reporting a cumulative total later means controlling the moment and the framing. Until the first reporting weekend actually happens, nobody outside the company knows which of those two things has been agreed to.

And the reversal does not resolve the underlying argument, which was always more interesting than the accounting. Netflix’s original claim was not that box office was unflattering. It was that box office was a bad measure of how many people watch a film, and on that narrow point the company was right and still is. A ticket sold is one person in one seat. A film on a service can be watched by a household of five and counted once, or left half-finished by a million people and counted as a million views. Every number in this business is a story someone chose to tell. The difference is that the theatrical number is audited by a hundred years of habit and everyone has agreed what it means, and the streaming number is whatever the company that owns the data says it is.

That is probably the real concession here. Not that Netflix has admitted box office matters, but that it has admitted an externally checkable number carries a kind of weight that an internal one never will, no matter how large the internal one is. Eleven years of insisting otherwise ended not with an argument lost but with a business that finally had something it wanted to prove to people who only accept one kind of proof.

The first test comes with the Spanish-language release in the autumn, the one with the long window and the awards campaign behind it. It will be the first time in the company’s history that anyone outside it will be able to open a trade paper on a Monday morning and read what a Netflix film made, in a figure the company itself supplied. Whether the figure is big or small, the era of not knowing is over for those six titles, and probably, eventually, for the rest.

Somewhere in a Netflix office there is a person who has spent a decade declining that exact question from reporters. They are about to have a very different job.